CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 224,497	$ 243,576
Trade accounts receivable, net of allowances of $387 and $444 at March 31, 2024 and December 31, 2023, respectively	95,484	108,240
Deferred contract costs	24,514	23,508
Prepaid expenses	21,314	14,255
Other current assets	20,913	13,055
Total current assets	386,722	402,634
Equipment and leasehold improvements, net	14,858	15,184
Goodwill	885,041	887,121
Other intangible assets, net	177,253	187,891
Deferred contract costs, non-current	54,040	53,070
Other assets	45,838	43,752
Total assets	1,563,752	1,589,652
Current liabilities:
Accounts payable	20,388	25,909
Accrued liabilities	70,533	77,447
Income taxes payable	1,346	1,248
Deferred revenue	311,698	317,546
Total current liabilities	403,965	422,150
Deferred revenue, non-current	52,805	55,886
Deferred tax liability, net	5,515	5,952
Convertible senior notes, net	367,626	366,999
Other liabilities	17,771	21,118
Total liabilities	847,682	872,105
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.001 par value, 50,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023	0	0
Common stock, $0.001 par value, 500,000,000 shares authorized at March 31, 2024 and December 31, 2023; 128,333,366 and 126,938,102 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	126	126
Additional paid‑in capital	1,183,852	1,162,993
Accumulated other comprehensive loss	(28,589)	(26,777)
Accumulated deficit	(439,319)	(418,795)
Total stockholders’ equity	716,070	717,547
Total liabilities and stockholders’ equity	$ 1,563,752	$ 1,589,652